These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 38635528)

  • 21. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
    Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
    Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.
    Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S
    Front Oncol; 2021; 11():651622. PubMed ID: 34367952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
    Yan C; Niu Y; Ma L; Tian L; Ma J
    J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic model of patients with liver cancer based on tumor stem cell content and immune process.
    Kong W; Gao M; Jin Y; Huang W; Huang Z; Xie Z
    Aging (Albany NY); 2020 Aug; 12(16):16555-16578. PubMed ID: 32852285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma.
    Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q
    J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Model of Basement Membrane-Associated Gene Signature Predicts Liver Hepatocellular Carcinoma Response to Immune Checkpoint Inhibitors.
    Shen J; Wei Z; Lv L; He J; Du S; Wang F; Wang Y; Ni L; Zhang X; Pan F
    Mediators Inflamm; 2023; 2023():7992140. PubMed ID: 37152370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis.
    He Q; Fan B; Du P; Jin Y
    Front Cell Dev Biol; 2022; 10():806989. PubMed ID: 35356272
    [No Abstract]   [Full Text] [Related]  

  • 29. Integrated analysis of ferroptosis and stemness based on single-cell and bulk RNA-sequencing data provide insights into the prognosis and treatment of esophageal carcinoma.
    Sui X; Wang W; Zhang D; Xu J; Li J; Jia Y; Qin Y
    Gene; 2024 Nov; 927():148701. PubMed ID: 38885819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Biomarkers Associated with Hepatocellular Carcinoma Stem Cell Characteristics Based on Co-Expression Network Analysis of Transcriptome Data and Stemness Index.
    Zhao Z; Mu H; Feng S; Liu Y; Zou J; Zhu Y
    Crit Rev Eukaryot Gene Expr; 2022; 32(2):47-60. PubMed ID: 35381131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of stemness features and construction of a stemness subtype classifier to predict survival and treatment responses in lung squamous cell carcinoma.
    Lai J; Lin X; Zheng H; Xie B; Fu D
    BMC Cancer; 2023 Jun; 23(1):525. PubMed ID: 37291533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices.
    Cai JL; Zhu GQ; Du JX; Wang B; Wan JL; Xiao K; Dai Z
    Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):699-709. PubMed ID: 33131341
    [No Abstract]   [Full Text] [Related]  

  • 34. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.
    Liu Y; Meng J; Ruan X; Wei F; Zhang F; Qin X
    Sci Rep; 2024 Jan; 14(1):746. PubMed ID: 38185671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients.
    Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z
    Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
    Yu X; Zhang J; Yang R; Li C
    Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An individualized stemness-related signature to predict prognosis and immunotherapy responses for gastric cancer using single-cell and bulk tissue transcriptomes.
    Zheng L; Chen J; Ye W; Fan Q; Chen H; Yan H
    Cancer Med; 2024 Jan; 13(1):e6908. PubMed ID: 38168907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
    Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
    Front Immunol; 2022; 13():994019. PubMed ID: 36177006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of stemness-related genes TIMP1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq.
    Shen Y; Ni S; Li S; Lv B
    Cancer Med; 2023 May; 12(10):11611-11623. PubMed ID: 37017587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
    Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
    Front Immunol; 2022; 13():990790. PubMed ID: 36248822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.